Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1988 1
1989 3
1990 5
1991 1
1993 2
1994 6
1995 4
1996 4
1997 4
1998 2
1999 7
2000 11
2001 9
2002 9
2003 9
2004 11
2005 12
2006 10
2007 12
2008 15
2009 7
2010 11
2011 17
2012 18
2013 19
2014 14
2015 20
2016 16
2017 18
2018 14
2019 9
2020 10
2021 9
2022 7
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.
McCarthy C, Gupta N, Johnson SR, Yu JJ, McCormack FX. McCarthy C, et al. Lancet Respir Med. 2021 Nov;9(11):1313-1327. doi: 10.1016/S2213-2600(21)00228-9. Epub 2021 Aug 27. Lancet Respir Med. 2021. PMID: 34461049 Review.
Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising neoplasm of women, characterised by infiltration of the lung parenchyma with abnormal smooth muscle-like cells, resulting in cystic lung destruction. ...
Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising neoplasm of women, characterised by infiltration of …
Lymphangioleiomyomatosis.
Xu KF, Xu W, Liu S, Yu J, Tian X, Yang Y, Wang ST, Zhang W, Feng R, Zhang T. Xu KF, et al. Semin Respir Crit Care Med. 2020 Apr;41(2):256-268. doi: 10.1055/s-0040-1702195. Epub 2020 Apr 12. Semin Respir Crit Care Med. 2020. PMID: 32279296 Review.
Lymphangioleiomyomatosis (LAM) is a slow albeit progressive rare neoplastic disease featured with diffuse thin-walled cysts in lungs and angiomyolipomas in kidneys. ...
Lymphangioleiomyomatosis (LAM) is a slow albeit progressive rare neoplastic disease featured with diffuse thin-walled cysts in lungs …
Chylothorax and Pseudochylothorax.
Braun CM, Ryu JH. Braun CM, et al. Clin Chest Med. 2021 Dec;42(4):667-675. doi: 10.1016/j.ccm.2021.08.003. Clin Chest Med. 2021. PMID: 34774173 Review.
The Genetics of Pneumothorax.
Boone PM, Scott RM, Marciniak SJ, Henske EP, Raby BA. Boone PM, et al. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1344-1357. doi: 10.1164/rccm.201807-1212CI. Am J Respir Crit Care Med. 2019. PMID: 30681372 Free PMC article. Review.
We summarize the pneumothorax-associated genetic syndromes, including Birt-Hogg-Dube syndrome, Marfan syndrome, vascular (type IV) Ehlers-Danlos syndrome, alpha-1 antitrypsin deficiency, tuberous sclerosis complex/lymphangioleiomyomatosis, Loeys-Dietz syndrome, cystic fibr …
We summarize the pneumothorax-associated genetic syndromes, including Birt-Hogg-Dube syndrome, Marfan syndrome, vascular (type IV) Ehlers-Da …
Tuberous sclerosis complex.
Henske EP, Jóźwiak S, Kingswood JC, Sampson JR, Thiele EA. Henske EP, et al. Nat Rev Dis Primers. 2016 May 26;2:16035. doi: 10.1038/nrdp.2016.35. Nat Rev Dis Primers. 2016. PMID: 27226234 Review.
Remarkable progress in basic and translational research, in addition to several randomized controlled trials worldwide, has led to regulatory approval of the use of mTOR inhibitors for the treatment of renal angiomyolipomas, brain subependymal giant cell astrocytomas and pulmonar …
Remarkable progress in basic and translational research, in addition to several randomized controlled trials worldwide, has led to regulator …
Tuberous sclerosis: a review of the past, present, and future.
Uysal SP, Şahin M. Uysal SP, et al. Turk J Med Sci. 2020 Nov 3;50(SI-2):1665-1676. doi: 10.3906/sag-2002-133. Turk J Med Sci. 2020. PMID: 32222129 Free PMC article. Review.
Subependymal giant cell astrocytomas, renal angiomyolipomas, and epilepsy are the three FDA-approved indications in relation to TSC for the use of everolimus, which is a first generation mTOR inhibitor. Rapamycin has been FDA approved for lymphangioleiomyomatosis. Other TS …
Subependymal giant cell astrocytomas, renal angiomyolipomas, and epilepsy are the three FDA-approved indications in relation to TSC for the …
Diffuse Cystic Lung Disease. Part II.
Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Gupta N, et al. Am J Respir Crit Care Med. 2015 Jul 1;192(1):17-29. doi: 10.1164/rccm.201411-2096CI. Am J Respir Crit Care Med. 2015. PMID: 25906201 Free PMC article. Review.
A wide variety of pathophysiological processes spanning the spectrum from airway obstruction to lung remodeling can lead to multifocal cyst development in the lung. Although lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis are perhaps more frequently se …
A wide variety of pathophysiological processes spanning the spectrum from airway obstruction to lung remodeling can lead to multifocal cyst …
Hemangioendothelioma.
Requena L, Kutzner H. Requena L, et al. Semin Diagn Pathol. 2013 Feb;30(1):29-44. doi: 10.1053/j.semdp.2012.01.003. Semin Diagn Pathol. 2013. PMID: 23327728 Review.
[Tuberous sclerosis complex: A review].
Pfirmann P, Combe C, Rigothier C. Pfirmann P, et al. Rev Med Interne. 2021 Oct;42(10):714-721. doi: 10.1016/j.revmed.2021.03.003. Epub 2021 Apr 6. Rev Med Interne. 2021. PMID: 33836894 Review. French.
Several randomized controlled trials led to regulatory approval of the use of mTOR inhibitors for the treatment of renal angiomyolipomas, brain subependymal giant cell astrocytomas, refractory epilepsy and pulmonary lymphangioleiomyomatosis....
Several randomized controlled trials led to regulatory approval of the use of mTOR inhibitors for the treatment of renal angiomyolipomas, br …
Diffuse Cystic Lung Disease. Part I.
Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Gupta N, et al. Am J Respir Crit Care Med. 2015 Jun 15;191(12):1354-66. doi: 10.1164/rccm.201411-2094CI. Am J Respir Crit Care Med. 2015. PMID: 25906089 Free PMC article. Review.
In the first of a two-part series, we present an overview of the cystic lung diseases caused by neoplasms, infections, smoking-related diseases, and interstitial lung diseases, with a focus on lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis....
In the first of a two-part series, we present an overview of the cystic lung diseases caused by neoplasms, infections, smoking-related disea …
313 results